Piper Jaffray Remains Bullish on Illumina (ILMN) Following EPS Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Janney Capital Downgrades Illumina (ILMN) to Neutral
July 22, 2015 8:08 AM EDTJanney Capital downgraded Illumina (NASDAQ: ILMN) from Buy to Neutral with a price target of $240 (unchanged).
For an analyst ratings summary and ratings history on Illumina click here. For more ratings news on Illumina click here.
Shares of Illumina closed at $237.54 yesterday.
... MoreMizuho Securities Raised Price Target on Illumina (ILMN) Following EPS Beat
July 22, 2015 7:30 AM EDTMizuho Securities maintained a Buy rating on Illumina (NASDAQ: ILMN), and raised the price target to $240.00 (from $230.00), ILMN reported EPS of $0.80, beating consensus by 3c. Analyst Peter Lawson said that he would be a buyer on any weakness.
Lawson commented, "We... More
After-Hours Stock Movers 07/21: (ISRG) (NUAN) (GPRO) Higher; (ILMN) (EXEL) (AAPL) Lower (more...)
July 21, 2015 5:31 PM EDTIntuitive Surgical (NASDAQ: ISRG) 13.3% HIGHER; reported Q2 EPS of $4.57, $0.59 better than the analyst estimate of $3.98. Revenue for the quarter came in at $586.1 million versus the consensus estimate of $566.86 million.
Illumina (NASDAQ: ILMN) 11.6% LOWER; reported Q2 EPS of $0.80, $0.03 better than the analyst estimate of $0.77. Revenue for the quarter came in at $539 million versus the consensus estimate of $541.77 million. Illumina sees FY2015 EPS of $3.39-$3.45, versus the consensus of $3.44.
Exelixis, Inc. (Nasdaq:... More
Illumina (ILMN) Tops Q2 EPS by 3c; Updates FY15 EPS Outlook
July 21, 2015 4:09 PM EDTIllumina (NASDAQ: ILMN) reported Q2 EPS of $0.80, $0.03 better than the analyst estimate of $0.77. Revenue for the quarter came in at $539 million versus the consensus estimate of $541.77 million.
Illumina sees FY2015 EPS of $3.39-$3.45, versus the consensus of $3.44.
For earnings history and earnings-related data on Illumina (ILMN) click here.
... MoreIllumina (ILMN) Appoints New SVP
July 20, 2015 4:20 PM EDTIllumina (NASDAQ: ILMN) announced that Sanjay Chikarmane has been named Senior Vice President and General Manager of Illuminas Enterprise Informatics business. Chikarmane will lead the development and commercialization of products and services aimed at turning genomic data into actionable information for researchers and clinicians. He will report to Illumina President, Francis deSouza.
Given the growing data intensive demands of the... More
